Showing 5981-5990 of 10173 results for "".
- Study Uncovers How B Cells React to Melanomahttps://practicaldermatology.com/news/study-uncovers-how-b-cells-react-to-melanoma/2461773/Antibody-producing B cells may be defective in responding to melanoma, a new study suggests. The study is published in Nature Communications. Researchers used advanced technologies to delve into the antibody immune response in blood and tissues of patients with m
- Does IL-17 Play a Role in Skin Aging?https://practicaldermatology.com/news/does-il-17-play-a-role-in-skin-aging/2461770/Interleukin (IL)-17 may plays a central role in skin aging, according to research from Institute for Research in Biomedicine (IRB Barcelona) in collaboration with the National Center for Genomic Analysis (CNAG). The study, which was led by Dr. Guiomar Solanas, Dr. Salvador Azn
- Researchers Uncover Clues Driving PsO Spread and Severityhttps://practicaldermatology.com/news/researchers-uncover-clues-driving-pso-spread-and-severity/2461759/New research sheds light on the cellular changes that drive psoriasis severity and also offers important clues about how the disease spreads to other parts of the body. Specifically, the location of clusters of fibroblasts and macrophages tend to occur more commonly in the upper l
- Memory Killer Cells May Boost Survival in Melanomahttps://practicaldermatology.com/news/memory-killer-cells-may-boost-survival-in-melanoma/2461758/High levels of memory killer cells in cancer tissue may boost survival in people with melanoma, a new study shows. Certain immune T cells called tissue-resident memory cells are formed locally in the skin and other tissue and protect against infections that they have encountered before.
- TWi Biotechnology, Yale University Seek Participants With GA for Phase 1 trial of a Topical JAK Inhibitorhttps://practicaldermatology.com/news/twi-biotechnology-yale-university-seek-participants-with-ga-for-phase-1-trial-of-a-topical-jak-inhibitor/2461757/TWi Biotechnology (TWiB) is seeking participants for a Phase 1 clinical trial of a topical gel form of tofacitinib for the treatment of granuloma annulare (GA). Individuals with GA or friends and family members can find study information at:
- Scientists Identify Genomic Cause and Potential Treatment for Disabling Pansclerotic Morpheahttps://practicaldermatology.com/news/scientists-identify-genomic-cause-and-potential-treatment-for-disabling-pansclerotic-morphea/2461756/Researchers have identified genomic variants that cause disabling pansclerotic morphea and have found a potential treatment. People with the disorder have an overactive version of a protein called STAT4, which regulates inflammation and wound healing. The work also identified a drug tha
- EULAR News: Tremyfa Data Shows Sustained Improvements in PsAhttps://practicaldermatology.com/news/eular-news-tremyfa-data-showing-sustained-improvements-in-psa/2461755/Tremfya (guselkumab) provides sustainable improvements in all minimal disease activity (MDA) domains through week 48 in adults with active psoriatic arthritis (PsA) who previously had an inadequate response to one to two tumor necrosis factor inhibitors (TNFi-IR), according to new data
- News You Can Use: AARS Launches Social Media Toolkit for #Acne Awareness Monthhttps://practicaldermatology.com/news/aars-launches-social-media-toolkit-for-acne-awareness-month/2461754/The American Acne and Rosacea Society (AARS) has launched a social media toolkit to help dermatology medical professionals who are their members share #acnefacts in recognition of Acne Awareness Month in June, The toolkit is available at acneandrosacea.org/acne-awareness-social- me
- Castle Biosciences Gives Back for Skin Cancer Awareness Monthhttps://practicaldermatology.com/news/castle-biosciences-gives-back-for-skin-cancer-awareness-month/2461750/Castle Biosciences, Inc. is teaming up with The Sun Bus and The Skin Cancer Foundation to support skin cancer prevention, research, education and advocacy. “At our core, we are passionate about transforming disease management, improving health and making a meaningful difference in
- Survey Highlights Room for Improvement in AK Awarenesshttps://practicaldermatology.com/news/survey-highlights-room-for-improvement-in-ak-awareness/2461746/As many as 85% of people are unaware of actinic keratosis (AK), according to a new survey from Almirall. The survey of more than 2,500 participants over the age or 35 aimed to understand the level of knowledge about AK and skin health habits within the general population of Spain, Germa